Abstract Chimeric antigen receptor T (CAR-T) cells are a promising new treatment for patients with relapsed or refractory hematologic malignancies. including lymphoma. Given the success of CAR-T cells directed against CD19. new targets are being developed and tested. https://leoners.shop/product-category/adjustable-base/